Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Brunswick Scientific (NBS) was a premier global manufacturer of laboratory equipment and instrumentation for the life science industry, particularly renowned for its pioneering work in bioreactors and fermentation technology. Founded in 1946, the company became a cornerstone of the biotech sector by providing critical infrastructure for cell culture, including shakers, CO2 incubators, and ultra-low temperature freezers. Its products were instrumental in the development of vaccines and biopharmaceuticals throughout the 20th century. In 2007, the company was acquired by Eppendorf AG, which integrated the NBS product line into its broader portfolio of laboratory solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Brunswick Union.